Doxycycline clearance of experimentally induced chronic Ehrlichia canis infection in dogs.
BACKGROUND
Ineffective clearance of Ehrlichia canis after doxycycline administration has been reported despite the fact that the recommended treatment for canine ehrlichiosis is doxycycline. The effectiveness of doxycycline in clearing E canis infection from the blood and tissues of dogs requires additional evaluation.


OBJECTIVE
Doxycycline (5 mg/kg PO q12h), administered for 4 weeks, will eliminate E canis infection from the blood and tissues of experimentally infected dogs.


METHODS
Fifteen Walker hound-mixed breed dogs were inoculated subcutaneously with E canis-infected canine histiocytic cells 4 months before doxycycline treatment.


METHODS
Four dogs were treated with doxycycline (5 mg/kg PO q12h for 3 weeks), 5 dogs were treated with doxycycline at the same dosage for 4 weeks, and 5 control dogs were not treated. Dexamethasone (0.4 mg/kg i.v.) was given after treatment to precipitate recrudescence of any remaining E canis organisms. Platelet counts, anti-E canis immunofluorescent antibodies, and polymerase chain reaction (PCR) detection of E canis deoxyribonucleic acid (DNA) in blood and tissues were evaluated.


RESULTS
E canis DNA was not detected in the blood and tissues of doxycycline-treated dogs after treatment. Platelet counts were within reference intervals, and E canis antibodies decreased. Spontaneous clearance of E canis infection occurred in 2 of 5 control dogs. Three control dogs had E canis DNA detected in blood and tissues, platelet counts remained low or within the reference interval, and E canis antibodies remained high.


CONCLUSIONS
As administered in this study, doxycycline cleared E canis from the blood and tissues of experimentally infected dogs.
Eddlestone
S M
SM
Department of Veterinary Clinical Sciences, Louisiana State University, School of Veterinary Medicine, Veterinary Clinical Sciences, Skip Bertman Drive, Baton Rouge, LA 7080, USA. seddlestone@vetmed.lsu.edu
Diniz
P P V P
PP
Neer
T M
TM
Gaunt
S D
SD
Corstvet
R
R
Cho
D
D
Hosgood
G
G
Hegarty
B
B
Breitschwerdt
E B
EB
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D004318:Doxycycline / Q000627:therapeutic use*; D041061:Ehrlichia canis; D016873:Ehrlichiosis / Q000188:drug therapy / Q000662:veterinary*
D000900:Anti-Bacterial Agents; D004318:Doxycycline